Imaging services firm Diagnostic Health Services of Dallas announced last month that it has closed its acquisition of the ultrasound division of Diagnostic Imaging Services of Los Angeles. The division was acquired for a combination of $7.5 million in
Imaging services firm Diagnostic Health Services of Dallas announced last month that it has closed its acquisition of the ultrasound division of Diagnostic Imaging Services of Los Angeles. The division was acquired for a combination of $7.5 million in cash and assumption of $1.5 million in debt.
The deal completes the first part of a transaction between Diagnostic Health and DIS that was announced earlier this year (SCAN 1/22/97). In the second part of the acquisition, Diagnostic Health will buy four hospital-based MRI centers owned by DIS. DHS estimates that the ultrasound and MRI acquisitions will add $11 million in revenues to the company.
In other Diagnostic Health news, the company last month reported financial results for 1996 that show revenues rising 41%. For the year, DHS posted revenues of $24.2 million, compared with $17.1 million in 1995. The company's net income was $2.5 million, compared with $1.2 million the year before.
DHS chairman and CEO Max Batzer said that the DIS acquisitions, along with several other of the company's purchases, will bring the company to a run rate of approximately $50 million for 1997.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Month, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.